Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:17:59 EST Sat 08 Nov 2025
Enter Symbol
or Name
USA
CA



News last 24 hour(s) - 40 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2025-11-08 17:45U:NKTRNews ReleaseNew Data from REZOLVE-AD Study of Rezpegaldesleukin Presented in Late-Breaking Oral Abstract Presentation at ACAAI 2025 Annual Scientific Meeting
2025-11-08 17:15U:VRTXNews ReleaseVertex Presents Updated Phase 1/2 Data From RUBY-3 Study That Continue to Demonstrate Best-in-Class Potential for Povetacicept in Adults with IgA Nephropathy and Primary Membranous Nephropathy at American Society of Nephrology Kidney Week
2025-11-08 17:13U:NTLANews ReleaseIntellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
2025-11-08 16:57U:ALNYNews ReleaseNew Post Hoc Analysis from the HELIOS-B Phase 3 Study Shows Vutrisiran Improved Measures of Heart Structure and Function in Patients with ATTR-CM
2025-11-08 16:30U:CNONews ReleaseMonumental Milestones at the 2025 CNO Financial Indianapolis Monumental Marathon
2025-11-08 14:30U:LXRXNews ReleaseClinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 2025
2025-11-08 14:30U:MRKNews ReleaseMerck's Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Phase 3 CORALreef Lipids Trial
2025-11-08 14:12U:REAXNews ReleaseReal Reaches Settlement in Principle in Litigation With Former CFO
2025-11-08 11:45U:VORNews ReleaseTelitacicept Achieved Primary Endpoint of Reducing Proteinuria in Stage A of a Phase 3 Clinical Study for IgA Nephropathy in China
2025-11-08 11:43U:FISNews ReleaseFIS Launches Innovative Asset Servicing Management Suite to Unlock Operational Efficiency Across Asset Servicing
2025-11-08 11:30U:GLUENews ReleaseMonte Rosa Therapeutics Presents Preclinical Data at AHA Scientific Sessions 2025 on the Potential of MRT-8102, a NEK7-directed Molecular Glue Degrader, to Treat Cardiovascular and Cardiometabolic Diseases
2025-11-08 11:25U:TNYANews ReleaseTenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK(TM)-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy
2025-11-08 11:00U:JBIONews ReleaseJade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrology Kidney Week 2025
2025-11-08 10:47U:REGNNews ReleasePhase 2 Trials Demonstrating Antithrombotic Effect of Two Novel Regeneron Factor XI Antibodies Presented at American Heart Association Scientific Sessions and Published in The Lancet
2025-11-08 10:41U:BBIONews ReleaseAcoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations
2025-11-08 10:10U:AMGNNews ReleaseAMGEN'S REPATHA(TM) CUTS RISK OF FIRST MAJOR ADVERSE CARDIOVASCULAR EVENTS BY 25% IN LANDMARK PHASE 3 VESALIUS-CV TRIAL
2025-11-08 09:56U:CRSPNews ReleaseCRISPR Therapeutics Announces Positive Phase 1 Clinical Data for CTX310(TM) Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and Lipid Lowering
2025-11-08 09:40U:IONSNews ReleaseGroundbreaking pivotal study results of olezarsen for severe hypertriglyceridemia (sHTG) presented as a late breaker at AHA Scientific Sessions
2025-11-08 08:00U:OGNNews ReleaseNew Data Show Early and Consistent Response to VTAMA(TM) (tapinarof) Cream, 1%, in Children Aged 2+ with Atopic Dermatitis, Including Those With Associated Comorbidities
2025-11-07 21:45U:CNNEFNews ReleaseCanacol Energy Ltd Provides Information on Arbitration Process
2025-11-07 21:31U:MTSRNews ReleasePfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer
2025-11-07 21:03U:AOTVFNews ReleaseAscot Announces Launch of C$0.01 Rights Offering
2025-11-07 20:52U:LWAYNews Release/C O R R E C T I O N -- Edward and Ludmila Smolyansky/
2025-11-07 20:37U:SURMFNews ReleaseSurface Metals Inc. Grants Options and Provides Update on Financial Marketing
2025-11-07 20:33U:PXEDNews ReleasePhoenix Education Partners Schedules Fourth Quarter and Full Year Earnings Conference Call
2025-11-07 20:07U:STSBFNews ReleaseSouth Star Announces Upsize of Non-Brokered Private Placement
2025-11-07 19:30U:SSHTNews ReleaseSSHT Announces Shareholder Plan to Acquire 10 Million Shares and Completes 220% Smart Production Capacity Expansion
2025-11-07 19:21U:ITGLFNews ReleaseIntegral Metals Announces Closing of Private Placement Offerings
2025-11-07 19:00U:CLGPFNews ReleaseNews Release
2025-11-07 19:00U:CTNTNews ReleaseCORRECTION - Cheetah Net Supply Chain Service Inc. Announces Third Quarter 2025 Results
2025-11-07 19:00U:FRHCNews ReleaseFreedom Holding Corp. Reports Financial Results for the Q2 FY2026 and 1H FY2026
2025-11-07 18:49U:TMQNews ReleaseTrilogy Metals Enters Into At-The-Market Equity Distribution Agreement
2025-11-07 18:49U:TMQNews ReleaseTrilogy Metals Enters Into At-The-Market Equity Distribution Agreement
2025-11-07 18:47U:NXTDFNews ReleaseNEXTGEN DIGITAL CLOSES FIRST TRANCHE OF NON-BROKERED PRIVATE PLACEMENT OF UNITS
2025-11-07 18:44U:USMTNews ReleaseUS Metro Bancorp Completes $31.9 Million Subordinated Note Capital Raise and Redemption of $16.0 Million Subordinated Note
2025-11-07 18:39U:NBYSEDAR Interim MD & ASEDAR Interim MD & A
2025-11-07 18:33U:NBYSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-11-07 18:31U:MRTMFNews ReleaseMaritime Resources Corp. Discloses Disposition of Common Shares of Emperor Metals Inc.
2025-11-07 18:27U:VERANews ReleaseVera Therapeutics Submits Biologics License Application to U.S. FDA through Accelerated Approval Program for Atacicept for the Treatment of Adults with IgA Nephropathy
2025-11-07 18:22U:PACNews ReleaseGrupo Aeroportuario del Pacifico Reports a Passenger Traffic Decrease In October 2025 of 0.8% Compared to 2024